N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer

Clinical and Experimental Metastasis

Volumn 25, Issue 2, 2008, Pages 97-108

  Martin, Tracey A ^a   Pereira, Gordon ^a   Watkins, Gareth ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Metastasis; N WASP; Nodal spread; Prognosis

Indexed keywords

NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; SCATTER FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; STAINING; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

EID: 41149173784     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9120-8     Document Type: Article

References (35)

1. Condeelis J, Singer RH, Segall JE (2005) The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 21:695-718
2. Van Den Bosch J, Drukker J (1964) The Aldrich Syndrome; a clinical and genetic study of several Dutch families. Maandschr Kindergeneeskd 32:359-73
3. Aldrich RA, Steinberg AG, Campbell DC (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13:133-139
4. Perry GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, Krivit W, Kersey JH (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr 97:72-78
5. ten Bensel RW, Stadlan EM, Krivit W (1996) The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68:761-767
6. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of Wiskott-Aldrich syndrome. J Pediatr 125:876-885
7. Symons M, Derry JMJ, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A (1996) Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723-734
8. Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T (1996) Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 93:5615-5618
9. Ochs HD, Thrasher AJ (2006) The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117(4):725-38
10. Welch MD, Mullins R.D (2002) Cellular control of actin nucleation. Annu Rev Cell Dev Biol 18:247-288
11. Notarangelo LD, Mazza C, Giliani S, D'Aria C, Gandellini F and Ravelli C, et al (2002) Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood 99:2268-2269
12. Burns S, Hardy S, Buddle J, Yong KL, Jones GE, Thrasher AJ (2004) Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 57:118-132
13. Miki H, Miura K, Takenawa T (1996) N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J 15(19):5326-5335
14. Zalevsky J, Lempert L, Kranitz H, Mullins RD (2001) Different WASP family proteins stimulate different Arp2/3 complex-dependent actin-nucleating activities. Curr Biol 11(24):1903-1913
15. Bretscher A (1989) Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 108(3):921-930
16. Hiscox S, Jiang WG (1999) Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 18(Pt 112):3081-3090
17. Kovacs EM, Makar RS, Gertler FB (2006) Tuba stimulates intracellular N-WASP-dependent actin assembly. J Cell Sci 119(Pt 13):2715-2726
18. Harrison G, Watkins G, Mansel RE, Jiang WG (2003) Expression and localisation of ezrin in human breast cancer and its association with clinical outcomes. Breast Cancer Res Treat 82(suppl 1):379
19. Jiang WG, Watkins G, Lane J, Douglas-Jones A, Cunnick GH, Mokbel M, Mansel RE (2003) Prognostic value of Rho family and and rho-GDIs in breast cancer. Clin Cancer Res 9(17):6432-6440
20. Jiang WG, Watkins G, Douglas-Jones A, Mansel RE (2004) Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes. Int J Oncol 25(1):81-85
21. Sturge J, Hamelin J, Jones GE (2002) N-WASP activation by a beta1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator. J Cell Sci 115(Pt 4):699-711
22. Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE, Jiang WG (2003) Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24(8):1317-1323
23. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mansel RE, Mason MD (2005) The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo. Int J Mol Med 16(4):723-728
24. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM (2005) Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 118(Pt 1):79-87
25. Parsons M, Monypenny J, Ameer-Beg SM, Millard TH, Machesky LM, Peter M, Keppler MD, Schiavo G, Watson R, Chernoff J, Zicha D, Vojnovic B, Ng T (2005) Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol Cell Biol 25(5):1680-1695
26. Higgs HN, Pollard TD (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J Cell Biol 150(6):1311-1320
27. Jones GE, Zicha D, Dunn GA, Blundell M, Thrasher A (2002) Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int J Biochem Cell Biol 34(7):806-815
28. Linder S, Nelson D, Weiss M, Aepfelbacher M (1999) Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci USA 96(17):9648-9653
29. Yamazaki D, Kurisu S, Takenawa T (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96(7):379-386
30. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J (2005) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 168(3):441-452
31. Sarrio D, Rodriguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J (2006) Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 98(1):71-79
32. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46(2):165-286
33. Manchanda N, Lyubimova A, Ho HY, James MF, Gusella JF, Ramesh N, Snapper SB, Ramesh V (2005) The NF2 tumor suppressor Merlin and the ERM proteins interact with N-WASP and regulate its actin polymerization function. J Biol Chem 280(13):12517-12522
34. Sukumvanich P, DesMarais V, Sermiento CV, Wang Y, Ichehovkin I, Mouneimne G (2004) Cellular localization of activated N-WASP using a conformation- sensitive antibody. Cell Motil Cytoskeleton 59(2):141-152
35. Suetsuga S, Takenawa T (2003) Translocation of N-WASP by nuclear localisation and export signals into the nucleus modulates expression of HSP90. J Biol Chem 278(43):42515-42523